These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 18452237)

  • 1. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring the AAV vector capsid for gene therapy.
    Vandenberghe LH; Wilson JM; Gao G
    Gene Ther; 2009 Mar; 16(3):311-9. PubMed ID: 19052631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the use of adeno-associated viral vectors for gene therapy.
    Büning H; Braun-Falco M; Hallek M
    Cells Tissues Organs; 2004; 177(3):139-50. PubMed ID: 15388988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant adeno-associated virus for skeletal gene therapy.
    Dai J; Rabie AB
    Orthod Craniofac Res; 2007 Feb; 10(1):1-14. PubMed ID: 17284242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
    Zaiss AK; Muruve DA
    Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
    Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M
    Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).
    Athanasopoulos T; Graham IR; Foster H; Dickson G
    Gene Ther; 2004 Oct; 11 Suppl 1():S109-21. PubMed ID: 15454965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.
    Maheshri N; Koerber JT; Kaspar BK; Schaffer DV
    Nat Biotechnol; 2006 Feb; 24(2):198-204. PubMed ID: 16429148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
    During MJ; Leone P
    Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
    Grieger JC; Samulski RJ
    Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive, real-time, RNA-specific PCR method for the detection of recombinant AAV-CFTR vector expression.
    Gerard CJ; Dell'Aringa J; Hale KA; Klump WM
    Gene Ther; 2003 Sep; 10(20):1744-53. PubMed ID: 12939641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
    Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
    Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV vectors for hemophilia B gene therapy.
    Chao H; Walsh CE
    Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The construction of a general adeno-associated virus vector].
    Yao E; Feng Z; Zheng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):147-50. PubMed ID: 12515194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of adeno-associated viral vectors.
    Grieger JC; Choi VW; Samulski RJ
    Nat Protoc; 2006; 1(3):1412-28. PubMed ID: 17406430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.